Skip to main content
. 2012 May 16;1(1):107–118.

Table 5.

Clinical characteristics of EOAD and FTD gene mutation carriers

Patient ID Mutation Sex Age at onset (years) Family history of dementia # relatives with AD or memory problems First clinical symptom(s)
506 APP p.Thr714Ile M 41 Yes 4 Memory loss
11323 PSEN1 p.Asn135Ser F 34 Yes 2 Memory loss
9018 PSEN1 p.Met146Leu F 41 Yes 2 Memory and language
711 PSEN1 p.Gly206Ala M 52 Yes 2 Memory loss
15066 PSEN1 p.Gly206Ala M 53 Yes 4 Memory loss
11967 PSEN1 p.Gly206Ala F 63 No 0 Memory loss and language
10232 PSEN1 p.Pro218Leu F 55 Yes 1 Memory and vision loss
15408 PSEN1 p.Ile238Met M 60 Yes 4 Memory and vision loss
14915 PSEN2 p.Ser130Leu F 52 No 0 Memory loss
8120 PSEN2 p.Met174Val F 45 Yes 1 Memory loss
15229 PSEN2 p.Phe183Ser F 46 Adopted unknown Memory loss
14330 GRN p.Arg198Glyfs19X M 62 No 0 Memory loss
15625 MAPT p.Arg406Trp M 50 Yes 5 Memory loss
9979 C9ORF72 repeat expansion M 68 Yes 1 Memory loss
7391 C9ORF72 repeat expansion F 69 No 0 Memory and gait loss

APP, amyloid precursor protein, PSEN1, presenilin 1, PSEN2, presenilin 2, GRN, progranulin, MAPT, microtubule associated protein tau, C9ORF72, chromosome 9 open reading frame 72.